Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Effectiveness and Implementation of a Personalized mHealth Intervention for the Universal Prevention of Maternal Perinatal Mental Disorders (ePerinatal-RCT)

25. maj 2026 opdateret af: Emma Motrico, University of Seville

Universal Prevention of Maternal Perinatal Mental Disorders and Its Implementation as Normalized Routine Practice (e-Perinatal): A Cluster Randomized Hybrid Effectiveness-Implementation Trial

This study is part of the ERC-funded e-Perinatal project and represents a large-scale hybrid type 1 effectiveness-implementation cluster randomized controlled trial. The primary aim is to evaluate the effectiveness of a personalized and complex mobile health (mHealth) intervention (e-Perinatal) in the universal prevention of maternal perinatal depression and anxiety disorders. Secondary aims include evaluating the impact on paternal mental health and child development, as well as examining implementation outcomes in real-world primary healthcare settings.

Studieoversigt

Detaljeret beskrivelse

This clinical trial evaluates the effectiveness and implementation of the e-Perinatal intervention, a personalized mobile health (mHealth) psychological program designed for the universal prevention of maternal perinatal depression and anxiety disorders. The study will be conducted as a two-arm, cluster-randomized, hybrid type 1 effectiveness-implementation trial in routine maternal care settings within primary healthcare centers.

Primary healthcare centers will be randomized to either the intervention or control arm. Participants will include pregnant women and their partners.

The primary objective is to evaluate the effectiveness of the e-Perinatal intervention in reducing the cumulative incidence of maternal perinatal depression and anxiety disorders, assessed via structured diagnostic interviews. Secondary objectives include assessing maternal and paternal mental health outcomes, child development outcomes, and identifying moderators and mediators of intervention effectiveness.

In addition, the study will evaluate implementation outcomes, including acceptability, feasibility, adoption, fidelity, and barriers and facilitators to implementation in real-world healthcare settings.

Participants in the intervention group will receive access to the e-Perinatal app alongside usual maternal care. The e-Perinatal app includes: 1) Digital micro-interventions focused on psychological, physical activity, and healthy lifestyle domains; 2) a personalized recommendation engine; 3) a social support section; 4) mental health monitoring; 5) an 'SOS' button for assistance; and 6) an appointment reminder tool. Participants in the control group will receive usual maternal care.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

3000

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Emma Motrico, PhD Psychology
  • Telefonnummer: 0034636995778
  • E-mail: eperinatal@us.es

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ja

Beskrivelse

Inclusion Criteria:

- Inclusion Criteria (Women)

Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers

Must be pregnant for at least 11 weeks at the time of enrollment

Must be at least 18 years old

Must have access to a mobile phone and internet connection

Must be able to read, write, and understand Spanish

Must have a personal email account

No diagnosis of depression or anxiety disorder at baseline Forma

- Inclusion Criteria (Partners or significant others)

Must receive an invitation to participate from a woman already enrolled in the study

Must be at least 18 years old

Must have access to a mobile phone and internet connection

Must be able to read, write, and understand Spanish

Must have a personal email account

Exclusion Criteria:

  • Exclusion Criteria (Women)

Current diagnosis of depression or anxiety disorder

Receiving psychological or pharmacological treatment for mental health or substance use conditions

- Exclusion criteria for partners (or significant others):

There are no exclusion criteria for partners

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Interventionsgruppe

The e-Perinatal intervention is a personalized mobile health (mHealth) program that includes: 1) Digital micro-interventions focused on psychological, physical activity, and healthy lifestyle domains; 2) a personalized recommendation engine; 3) a social support section; 4) mental health monitoring; 5) an 'SOS' button for assistance; and 6) an appointment reminder tool. The intervention is delivered through a mobile application and is integrated into routine maternal care.

Participants will use the app from recruitment (pregnancy) until 12 months of postpartum.

Aktiv komparator: Kontrolgruppe
Participants will receive standard maternal care as provided by the public healthcare system, including routine antenatal and postnatal visits and access to maternal education programs.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cumulative incidence of maternal perinatal depression and anxiety disorders
Tidsramme: Baseline and 12 months postpartum
Assessment method: Composite Internacional Diagnosis Interview (CIDI), based on DSM-5 criteria
Baseline and 12 months postpartum

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Maternal depressive symptoms (mothers)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Changes in depressive symptoms. Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Maternal anxiety symptoms (mothers)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Changes in anxiety symptoms. Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Paternal depressive symptoms (partner)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Changes in depressive symptoms. Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Paternal anxiety symptoms (partner)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Changes in anxiety symptoms. Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Psychological well-being (mothers, partners)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
Changes in subjective well-being. Assessment method: The Well-Being Index (WHO-5), a 5-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating better subjective well-being.
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Organisatorisk parathed til at implementere forandringer
Tidsramme: Målt før rekruttering
Organisationens parathed til at implementere ændringer i den sædvanlige pleje. Vurderingsmetode: The Organizational Readiness Implementing Change (ORIC), en selvrapporteringsforanstaltning med 12 punkter. Hvert element scores fra 1 til 5, hvor højere score indikerer større parathed til at implementere forandring.
Målt før rekruttering
PHC egenskaber
Tidsramme: Målt før rekruttering
Størrelsen af ​​befolkningen, hvor PHC er placeret, og antallet af PHC-professionelle. Vurderingsmetode: Spørgeskema udviklet af forskerholdet
Målt før rekruttering
App quality (mothers, partners)
Tidsramme: 12 months postpartum
Objective and subjective quality, and the perceived impact of the application. Assessment method: The User Version of the Mobile Application Rating Scale (u-MARS), a 26-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better app quality.
12 months postpartum
Implementation process
Tidsramme: 12 months postpartum
App implementation process from the perspective of healthcare professionals involved in implementing complex interventions. Assessment method: The Normalization Measure Development Questionnaire (NoMAD), a 20-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating more effective implementation processes.
12 months postpartum
Barriers and facilitators
Tidsramme: 12 months postpartum
Identifies barriers and facilitators impacting the integration of the intervention into routine healthcare, drawing from the experiences of users and healthcare professionals. Assessment method: Semi-structured interviews following the Normalization Process Theory (NPT) framework
12 months postpartum
Reasons for dropout (mothers, partners)
Tidsramme: 12 months postpartum
Number and reasons (e.g., experienced miscarriage or stillbirth, lack of engagement with the app) for dropout among women and their partners. Assessment method: Records and semi structured interviews.
12 months postpartum
Antenatal and postnatal risks (mothers, partners)
Tidsramme: Baseline, 6 weeks postpartum
Measures both antenatal and postnatal risk factors. Assessment method: The Antenatal Risk Questionnaire (ANRQ-R), a 11-item self-report measure. Some items are scored from 1 to 5 and others are scored on categorical scale, with higher scores indicating greater risk.
Baseline, 6 weeks postpartum
Basic psychological needs (mothers, partners)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Measures the satisfaction and frustration of basic psychological needs. Assessment method: The Basic Psychological Need Satisfaction and Frustration Scale - Short Form (BPNSFS), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating a higher need satisfaction (i.e., need satisfaction subscale) or a higher need frustration (i.e., need frustration subscale).
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Maternal post-traumatic stress symptoms (mothers)
Tidsramme: 6 weeks postpartum
Presence of post-traumatic stress symptoms after childbirth. Assessment method: City Birth Trauma Scale (City-BiTS), a 5-item self-report measure. A total of 4 items are scored from 0 to 3 and one item is scored from 0 to 1, with higher scores indicating greater severity of postnatal post-traumatic stress.
6 weeks postpartum
Maternal perceptions of childbirth (mothers)
Tidsramme: 6 weeks postpartum
Measure of the perceived quality of the childbirth experience. Assessment method: Childbirth Experience Questionnaire (CEQ-E), a 22-items self-report scale. A total of 19 items range from 1 to 4. A total of 2 items range from 0 to 10. Higher scores indicate a more positive experience of childbirth.
6 weeks postpartum
Maternal breastfeeding experience (mothers)
Tidsramme: 6 weeks postpartum; 6 months postpartum
Assessment method: Ad hoc instrument. The instrument assesses infant feeding practices (2 items) and maternal satisfaction with breastfeeding (1 item), yielding a score ranging from 0 to 100. Higher scores indicate greater satisfaction with breastfeeding.
6 weeks postpartum; 6 months postpartum
Maternal antenatal attachment (mothers)
Tidsramme: 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Measures the level of maternal antenatal attachment to the baby. Assessment method: The Maternal Antenatal Attachment Scale (MAAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal antenatal attachment.
34-36 weeks of gestation (for participants enrolled before 31 weeks)
Paternal antenatal attachment (partners)
Tidsramme: 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Measures the level of paternal antenatal attachment to the baby. Assessment method: The Paternal Antenatal Attachment Scale (PAAS), a 16-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal antenatal attachment.
34-36 weeks of gestation (for participants enrolled before 31 weeks)
Maternal postnatal attachment (mothers)
Tidsramme: 6 weeks postpartum
Measures the level of maternal postnatal attachment to the baby. Assessment method: The Maternal Postnatal Attachment Scale (MPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal postnatal attachment.
6 weeks postpartum
Paternal postnatal attachment (fathers)
Tidsramme: 6 weeks postpartum
Measures the level of postnatal attachment to the baby in both mothers and fathers. Assessment method: The Paternal Postnatal Attachment Scale (PPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal postnatal attachment.
6 weeks postpartum
Psychological flexibility (mothers, partner)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Measure of psychological flexibility. Assessment method: Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT), a 10-item self-report scale. Each item is scored from 1 to 7, with higher scores indicating greater psychological flexibilityTime
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Partnership quality (mothers, partners)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Measures the quality of the marital or partnership relationship. Assessment method: The Quality of Marriage Index (QMI), a 6-item self-report measure. Some items are scored from 1 to 7 and others from 1 to 10, with higher scores indicating better relationship quality.
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Parental role perception (mothers)
Tidsramme: 6 months postpartum
Measures parents' perception of their competence in the parental role. Assessment method: The Parental Sense of Competence scale (PSOC), a 21-item self-report measure. Each item is scored from 1 to 6, with higher scores indicating a stronger sense of parental competence.
6 months postpartum
Coparenting dynamics (mothers, partners)
Tidsramme: 6 months postpartum
Measures the dynamics of coparenting relationships. Assessment method: The Coparenting Relationship Scale (CRS), a 14-item self-report measure. Each item is scored from 0 to 6, with higher scores indicating more positive coparenting dynamics.
6 months postpartum
Mediterranean diet adherence (mothers, partners)
Tidsramme: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Measure of adherence to the mediterranean diet. Assessment method: Mediterranean Diet Adherence Screener (MEDAS), a 14-items self-report instrument. Each item score from 0 to 1. Higher scores indicate greater adherence to the mediterranean diet.
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
Maternal physical activity levels (mothers)
Tidsramme: Baseline, 6 months postpartum
Measures physical activity levels in pregnant women and mothers. Assessment method: The Pregnancy Physical Activity Questionnaire (PPAQ), a 33-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating higher levels of physical activity.
Baseline, 6 months postpartum
Physical condition (mothers)
Tidsramme: Baseline, 6 months postpartum
Measures overall physical condition and the main components (i.e., cardiorespiratory fitness, muscular strength, speed-agility, and flexibility) in pregnant women and mothers. Assessment method: The International FItness Scale (IFIS), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better physical condition.
Baseline, 6 months postpartum
Child temperament (mothers)
Tidsramme: 6 months postpartum
Measures various aspect of infant temperament. Assessment method: The Infant Behavior Questionnaire-Revised Short Form (IBQ-R SF), a 37-item self-report measure. Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.
6 months postpartum
Child development (mothers)
Tidsramme: 6 months postpartum

Measures of various domains of infant development. Assessment method: Ages & Stages Questionnaires (ASQ-3), a self-report measure. Each milestone question is answered using one of three frequency options, which are converted into point values:

  • Yes: 10 points (the child is performing the skill)
  • Sometimes: 5 points (the child is beginning to perform the skill or does it occasionally)
  • Not Yet: 0 points (the child does not yet perform the skill)
6 months postpartum
Life quality (mothers, partners)
Tidsramme: 12 months postpartum
Measures the overall quality of life. Assessment method: The European Quality of Life-5 Dimensions-5 Levels (EuroQol-5D-5L), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating worse quality of life
12 months postpartum
Identity (mothers, partners)
Tidsramme: Baseline, 6 months postpartum
Measure of various domains of identity development. Assessment method: Dimensions of Identity Development Scale (DIDS)., a 25-items self-report measure. Each item is scored from 1 to 5, with higher scores indicating greater endorsement of the corresponding identity development dimension.
Baseline, 6 months postpartum
Economic data
Tidsramme: 12 months postpartum
Measures healthcare service utilization and sick leave days over the previous year among participating women. Assessment method: a post hoc semi-structured interview that collects information on emergency visits, hospital admissions, primary care visits (e.g., nurse, midwife, social worker), secondary care visits, and consultations with specialists.
12 months postpartum

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Emma Motrico, PhD, University of Seville

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

30. maj 2026

Primær færdiggørelse (Anslået)

30. december 2027

Studieafslutning (Anslået)

30. marts 2028

Datoer for studieregistrering

Først indsendt

6. maj 2026

Først indsendt, der opfyldte QC-kriterier

25. maj 2026

Først opslået (Faktiske)

29. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

29. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

25. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • EP-WP3-2025
  • 101042139 (Anden identifikator: European Research Council (ERC))

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Perinatal depression

Abonner